MEDP Projected Dividend Yield

Medpace Holdings Inc ( NASDAQ : MEDP )

Medpace Holdings, Inc. provides global clinical research-based drug and medical device development services, focusing on outsourced clinical development for biotechnology, pharmaceutical, and medical device industries. They offer full-service Phase I-IV clinical development, including plan design, central lab coordination, project management, regulatory affairs, clinical monitoring, data management, pharmacovigilance, new drug application submissions, and post-marketing support. They also provide bio-analytical lab services, clinical human pharmacology, imaging, and electrocardiography support, with operations in North America, Europe, and Asia.

21 YEAR PERFORMANCE RESULTS